EMEA-002168-PIP01-17-M02
Key facts
| Active substance |
onasemnogene abeparvovec
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0315/2019
|
| PIP number |
EMEA-002168-PIP01-17-M02
|
| Pharmaceutical form(s) |
Solution for injection/infusion
|
| Condition(s) / indication(s) |
Treatment of spinal muscular atrophy
|
| Route(s) of administration |
|
| Contact for public enquiries |
AveXis EU Ltd
Tel. +351 308800322 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|